TRANSLATE

The mpn Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mpn Hub cannot guarantee the accuracy of translated content. The mpn and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The MPN Hub is an independent medical education platform, sponsored by AOP Health and GSK, and supported through an educational grant from Bristol Myers Squibb. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

REVEAL study: What have been the most common causes of mortality for patients with PV?

Featured:

Brady L. SteinBrady L. Stein

Dec 8, 2020


During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the MPN Hub spoke to Brady L. Stein, Northwestern University, Evanston, US, about the most common causes of mortality for patients with polycythemia vera (PV).

REVEAL study: What have been the most common causes of mortality for patients with PV?

Stein gives an overview of the key findings from the REVEAL study: patients who died during the study were older and categorized as high-risk (aged ≥ 60 years and/or history of thrombosis) at diagnosis compared with patients who were alive. The most common causes of death included: vascular complications, hematological transformations, and respiratory failure.

Your opinion matters

On average, how many patients with myelofibrosis do you see in a month?